Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France

• Hauptverfasser: Hamza Alshannaq (Verfasst von), Richard F Pollock (Verfasst von), Michael Joubert (Verfasst von), Waqas Ahmed (Verfasst von), Gregory J Norman (Verfasst von), Peter M Lync (Verfasst von), Stephane Roze (Verfasst von)
• Format: Buch
• Veröffentlicht: Becaris Publishing Limited, 2024-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Aim: Clinical trials and real-world data for Type II diabetes both show that glycated hemoglobin (HbA1c) levels and hypoglycemia occurrence can be reduced by real-time continuous glucose monitoring (rt-CGM) versus self-monitoring of blood glucose (SMBG). The present cost-utility study investigated t...